Serina Therapeutics SER
NYSE SER
$1.51 +0.07 (+4.86%)
At close: Nov 11, 2026 · 4:00 PM EST

Serina Therapeutics (SER) Cash from Discontinued Operations (2020 - 2021)

Updated

Serina Therapeutics' Cash from Discontinued Operations was -$250,000 in FY2021, compared with $191,000 in FY2020.

Analysis

Serina Therapeutics (SER) Cash from Discontinued Operations (2020 - 2021) Analysis & Trends

  • Per Business Quant data, Cash from Discontinued Operations in earlier years was $191,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discont. Ops (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 6.56 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Serina Therapeutics 23.59 Mn -35.63 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 -90,000.00
Dec 31, 2020 -1,000.00
Sep 30, 2020 108,000.00
Jun 30, 2020 -92,000.00
Mar 31, 2020 176,000.00
API Access

Serina Therapeutics Cash from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-discontinued-operations&ticker=SER&period=max&api_key=YOUR_API_KEY